- Home
- CRK vs KRYS Comparison
CRK vs KRYS Comparison
Compare CRK & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRK
- KRYS
- Stock Information
- Founded
- CRK 1983
- KRYS 2015
- Country
- CRK United States
- KRYS United States
- Employees
- CRK N/A
- KRYS N/A
- Industry
- CRK Oil & Gas Production
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CRK Energy
- KRYS Health Care
- Exchange
- CRK Nasdaq
- KRYS Nasdaq
- Market Cap
- CRK 4.2B
- KRYS 4.8B
- IPO Year
- CRK N/A
- KRYS 2017
- Fundamental
- Price
- CRK $15.83
- KRYS $164.83
- Analyst Decision
- CRK Hold
- KRYS Strong Buy
- Analyst Count
- CRK 11
- KRYS 7
- Target Price
- CRK $12.13
- KRYS $206.67
- AVG Volume (30 Days)
- CRK 2.0M
- KRYS 309.7K
- Earning Date
- CRK 02-11-2025
- KRYS 11-04-2024
- Dividend Yield
- CRK N/A
- KRYS N/A
- EPS Growth
- CRK N/A
- KRYS N/A
- EPS
- CRK N/A
- KRYS 1.77
- Revenue
- CRK $1,297,657,000.00
- KRYS $241,519,000.00
- Revenue This Year
- CRK N/A
- KRYS $485.65
- Revenue Next Year
- CRK $32.39
- KRYS $58.64
- P/E Ratio
- CRK N/A
- KRYS $92.96
- Revenue Growth
- CRK N/A
- KRYS 2722.80
- 52 Week Low
- CRK $7.07
- KRYS $107.50
- 52 Week High
- CRK $17.79
- KRYS $219.34
- Technical
- Relative Strength Index (RSI)
- CRK 56.88
- KRYS 40.33
- Support Level
- CRK $15.26
- KRYS $155.16
- Resistance Level
- CRK $16.45
- KRYS $176.59
- Average True Range (ATR)
- CRK 0.77
- KRYS 9.47
- MACD
- CRK -0.12
- KRYS -2.78
- Stochastic Oscillator
- CRK 47.03
- KRYS 23.79
About CRK Comstock Resources Inc.
Comstock Resources Inc is an independent energy company operating in the Haynesville shale, a natural gas basin located in East Texas and North Louisiana with superior economics and geographical proximity to the Gulf Coast markets. The Company operates in one business segment, the exploration and production of North American natural gas and oil. It is engaged in the acquisition, development, production, and exploration of oil and natural gas. Its oil and gas operations are concentrated in Louisiana and Texas.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.